Article | November 8, 2023

Revolutionizing Clinical Trials: The Power And Potential Of Risk-Based Monitoring

GettyImages-1394355488 data

Risk-based monitoring (RBM) commonly is conflated with remote monitoring or is assumed to eliminate on-site monitoring. In fact, all clinical trials require some on-site monitoring, and remote monitoring is just one element of RBM. Additional misconceptions surrounding RBM include diminished data quality, disruptive process changes, or inconsistency across operations. Also, RBM is sometimes believed to diminish trial oversight, when it actually increases overall trial oversight. It balances “must do” data collection and “nice-to-have” data against site and patient burden — and, more important, patient safety

However, all this flexibility introduces the challenge of change management when implementing RBM. Moving away from well-established monitoring parameters changes the mindset and processes for various stakeholders in the company. So, it involves overcoming resistance to change and managing the transition effectively through collaboration between the sponsor, each site, the CRO, and regulatory agencies.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader